a parenteral preparation injectable solutions, solutions for transmucosal administration, nasal solutions, otic solutions are preferred
Clinical trials reported nausea in 12-29% of participants, making it the single most common adverse event
If it still has not dissolved, there may be an issue with the peptide or the reconstitution method
EACH ML CONTAINS: CYANOCOBALMIN 1000MCG, BENZYL ALCOHOL 1.5%, SODIUM CHLORIDE FOR ISOTINICITY, SODIUM ACETATE AND ACETIC ACID AS BUFFERS, SODIUM HYDROXIDE AND/ OR HYDROCHLORIC ACID TO ADJUST Ph AND WATER FOR INJECTION
BMC Med 14, 103 (2016).
Yeah, not exactly what you expected from something called care. Its time to choose a better system